{
    "SPADE_N_13933": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13933",
            "Peptide Name": "Figainin 2BN (Leu-rich; natural AMPs; frog, amphibians, animals, UCLL1)",
            "Source": "norepinephrine-stimulated skin secretion, the Giant Gladiator Treefrog, the Rusty Treefrog,Boana boans, Trinidad, South America",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "FLGVALKLGKVLGKALLPLASSLLHSQ",
            "Sequence Length": 27,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2774.39,
            "PI": 10.3,
            "Hydrophobicity": 1.01,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Conlon JM, Guilhaudis L, Attoub S, Coquet L, Leprince J, Jouenne T, Mechkarska M. 2023",
                    "Reference": "Antibiotics (Basel). 2023 Jun 25;12(7):1102. doi: 10.3390/antibiotics12071102.Pub-Med.",
                    "Title": "Purification, Conformational Analysis and Cytotoxic Activities of Host-Defense Peptides from the Giant Gladiator Treefrog Boana boans (Hylidae: Hylinae)."
                }
            ],
            "Frequent Amino Acids": "LAG",
            "Absent Amino Acids": "CDEIMNORTUWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 16,
            "Polar Residues": 13,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "Net Charge": 4,
            "Comments": "Discovery: isolated chromatographically from pooled skin secretions.Sequence analysis: APD analysis reveals this sequence is most similar (53.13%) toCPF-SE2L: 33%; A=G=K: 11%; GRAVY: 1.00; M Wt: 2774.424; Mol formula:  C131H225N33O32; molar extinction coeff: 0.Activity: active against Gram+ S. aureus ATCC 12600 (MIC 7.8 uM), E. faecium ATCC 19439 (MIC 31.3 uM), E.faecalis ATCC 51299 (MIC 125 uM), Gram- E. coli ATCC 35218 (MIC 15.6 uM), K. pneumoniae ATCC 49472 (MIC 31.3 uM), and P. aeruginosa ATCC 9072 (MIC 31.3 uM). Also showed cytotoxicity to cancer cells ung adenocarcinoma A549 (LC50 6.7 uM), breast adenocarcinoma MDA-MB-231 cells (LC50 8.1 uM), and colorectal adenocarcinoma HT-29 cells (LC50 14.1 uM).Toxicity: non-neoplastic human umbilical vein endothelial cells HUVEC (LC50 15.1 uM). This peptide is toxic.Structure: random coil in water and became helical in the presence of 50% TFE, DPC or SDS micelles.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13396",
                    "Similarity": 0.7692307692307693,
                    "Sequence": "VWKWGKLGKLLKLGKLGK"
                },
                {
                    "SPADE_ID": "SPADE_N_09323",
                    "Similarity": 0.7333333333333333,
                    "Sequence": "FLGVVFKLASKVFGKVFGKV"
                },
                {
                    "SPADE_ID": "SPADE_UN_27711",
                    "Similarity": 0.7333333333333333,
                    "Sequence": "FLGVVFKLASKVFGKVFGKV"
                }
            ]
        }
    }
}